San Diego 2024-12-08
ELN Breakfast Meeting

The next ELN Breakfast Meeting is planned in San Diego at ASH on Sunday, 2024-12-08, 6-10 AM as usual

20.ELN/23.KNL Symposium, Mannheim, April 9, 2024

The 20.ELN/23.KNL Symposium will again take place at the Congress Center Rosengarten, Mannheim on April 9, 2024, 8:00 - 20:00, followed by a working dinner in the foyer. The Symposium will have 14 sessions including 12 research sessions on the various types of leukemia and interdisciplinary specialities, 1 plenary session for summary reports and 1 plenary session for 6 keynote lectures.

Information and invitation through

Sessions Programs
19. ELN / 22. KNL Symposium on April 18, 2023

Photos of the 19. ELN/22. KNL Symposium on April 18, 2023 (Group Photo, Keynote Lectures, Merit Awards) can be accessed here:

Photos 2023

Network info and goals

The ELN is an international network of excellence for cooperative research on leukemia. Ca. 220 participating centers in 45 countries (map attached) with more than 1000 researchers and clinicians are cooperating. The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN), their interdisciplinary partner groups (diagnostics, treatment research, registry, guidelines), industry and SMEs to form a network promoting cooperative research for curing leukemia. A summary of the mission of ELN is attached. 

Achievements of the ELN

Achievements in addition to the integration of leukemia research among its more than 1000 physicians and researchers and 220 institutions are the more than 100 management recommendations and guidelines for all types of leukemia and related interdisciplinary specialities. A selection of the recommendations 2013-2023 is included in the attachment. The key instrument of integration are regular meetings, in particular the annual ELN symposium  at no cost for participants

Definition and funding of the European LeukemiaNet

The European LeukemiaNet started as a publicly funded research network of excellence. Goal is cure of leukemia by integration of leukemia research and spread of excellence. The European LeukemiaNet was funded by the 6th Framework Program of the European Community until 2011, by the European Research Foundation until 2015 and is currently funded by the ELN-Foundation.

ELN Steering Committee (ELN SC)

ELN SC members

  • Jane Apperley
  • Tiziano Barbui
  • Marie C. Bené
  • William Blum
  • Lars Bullinger
  • Felipe Casado
  • Sabina Chiaretti
  • Jacqueline Cloos
  • Carlo Croce
  • Nick Cross
  • Michael Deininger
  • Hartmut Döhner
  • Hervé Dombret
  • Martin Dugas
  • Bianca Espinet
  • Pierre Fenaux
  • Robin Foa
  • Robert Peter Gale
  • Arnold Ganser
  • Laurent Gardaret
  • Paolo Ghia
  • Nicola Gökbuget 
  • Martin Griesshammer
  • Joelle Guilhot
  • Francois Guilhot
  • Claudia Haferlach
  • Torsten Haferlach
  • Jesus Hernandez
  • Michael Heuser
  • Andreas Hochhaus
  • Dieter Hoelzer
  • Jerzy Holowiecki
  • Gerwin Huls
  • Wiesław Jędrzejczak
  • Jean-Jacques Kiladjian
  • Hans-Jochem Kolb
  • Alexander Kulagin
  • Sergej Kulikov
  • Michael Lauseker
  • Per Ljungman
  • Elsa Lomaia
  • Francois-Xavier Mahon 
  • Luca Malcovati
  • Giovanni Martinelli
  • Michael Mauro
  • Moshe Mittelman
  • Ivan Moisiv
  • Carsten Müller-Tidow
  • Dietger Niederwieser
  • Gert Ossenkoppele
  • Elena Parovichnikova
  • Markus Pfirrmann
  • Andy Rawstron
  • Josep Ribera
  • Harald Rieder
  • Christoph Röllig
  • Gianantionio Rosti
  • Tapani Ruutu
  • Giuseppe Saglio
  • Miguel Sanz
  • Susanne Saußele
  • Lydia Scarfo
  • Hubert Serve
  • Richard Silver
  • Leif Stenke
  • Isolde Summerer
  • Christian Thiede
  • Theo de Witte
  • Gina Zini


  • Rüdiger Hehlmann
ELN Information (1.3 MB)
Information about the European LeukemiaNet